(Q45031559)

English

The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Jean-Louis Montastruc

7

object named as

Jean-Louis Montastruc

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Fulvio Bracco

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Angelo Battaglia

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Carlos Chouza

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Erik Dupont

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Oscar Gershanik

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Jose Felix Marti Masso

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PKDS009 Study Group

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

733-746

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Slowing Parkinson's disease progression: recent dopamine agonist trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of immediate-release and controlled release carbidopa/levodopa in Parkinson's disease. A multicenter 5-year study. The CR First Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Wearing-off fluctuations in Parkinson's disease: contribution of postsynaptic mechanisms.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice parameter: initiation of treatment for Parkinson's disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levodopa strengths and weaknesses

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pramipexole in patients with early Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Motor response to apomorphine and levodopa in asymmetric Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cabergoline in the treatment of early Parkinson's disease: results of the first year of treatment in a double-blind comparison of cabergoline and levodopa. The PKDS009 Collaborative Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial agonist treatment of Parkinson disease: a critique

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pergolide monotherapy in the treatment of early PD: a randomized, controlled study. Pergolide Monotherapy Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine agonists: what is the place of the newer compounds in the treatment of Parkinson's disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dopamine agonists in early therapy for Parkinson disease: promise and problems

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent advances in research on Parkinsonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/15330687

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00023210-200418110-00003

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45031559&oldid=2207057986"